Prevalence, breakpoint distribution, and clinical correlates of t(5;12)
- 30 September 2004
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 153 (2) , 170-172
- https://doi.org/10.1016/j.cancergencyto.2004.01.013
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Novel translocations that disrupt the platelet‐derived growth factor receptor β (PDGFRB) gene in BCR–ABL‐negative chronic myeloproliferative disordersBritish Journal of Haematology, 2003
- Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor BetaNew England Journal of Medicine, 2002
- Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor BetaActa Haematologica, 2002
- Myelodysplasia with fibrosis: a distinct entity?Leukemia Research, 2001
- Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocationCell, 1994